Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 8,903,838 | 8,903,838 | 0 | $141.39M | $120.47M | 91.50% | -$20.92M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,167,114 | 1,167,114 | 0 | $7.32M | $11.19M | 8.50% | +$3.87M |